Abbott Laboratories

NYSE: ABT · Real-Time Price · USD
129.32
-0.08 (-0.06%)
At close: Aug 14, 2025, 3:59 PM
129.76
0.34%
Pre-market: Aug 15, 2025, 06:00 AM EDT

Abbott Laboratories Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
41.95B 40.11B 43.65B 43.08B
Cost of Revenue
20.63B 20.07B 21.33B 19.86B
Gross Profit
21.32B 20.04B 22.32B 23.21B
Operating Income
6.85B 6.43B 8.36B 9.2B
Interest Income
344M 385M 183M 43M
Pretax Income
7.01B 6.66B 8.31B 8.21B
Net Income
13.4B 5.72B 6.93B 7.07B
Selling & General & Admin
11.65B 10.88B 11.11B 11.28B
Research & Development
2.82B 2.72B 2.85B 2.74B
Other Expenses
n/a n/a n/a n/a
Operating Expenses
14.47B 13.6B 13.96B 14.01B
Interest Expense
603M 698M 315M 410M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
35.1B 33.67B 35.29B 33.88B
Income Tax Expense
-6.39B 941M 1.37B 1.14B
Shares Outstanding (Basic)
1.73B 1.73B 1.75B 1.77B
Shares Outstanding (Diluted)
1.75B 1.75B 1.76B 1.79B
EPS (Basic)
7.74 3.30 3.94 3.97
EPS (Diluted)
7.64 3.27 3.91 3.94
EBITDA
10.83B 10.61B 11.89B 12.16B
EBIT
7.62B 7.36B 8.62B 8.62B
Depreciation & Amortization
3.22B 3.24B 3.27B 3.54B